Live Breaking News & Updates on Chemotherapy Technologies Inc

Stay updated with breaking news from Chemotherapy technologies inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Advanced Chemotherapy Technologies, Inc. Awarded $4 Million NIH Grant to Pursue Treatment for Locally Advanced Non-resectable Pancreatic Cancer

Advanced Chemotherapy Technologies, Inc. Awarded $4 Million NIH Grant to Pursue Treatment for Locally Advanced Non-resectable Pancreatic Cancer
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

North Carolina , United States , University Of North Carolina , Josephm Desimone , Jen Yeh , Sanjiv Sam Gambhir , National Cancer Institute , Carolina Biotechnology Center , Us National Institutes Of Health , Pioneer Award Program , University Cancer Research Fund , Lineberger Comprehensive Cancer Center , University Of North Carolina At Chapel Hill , Chemotherapy Technologies Act Inc , Pancreatic Cancer Center , Clinical Translational Research Program , National Institutes Of Health , Chemical Engineering At Stanford University , Department Of Surgery , Chemotherapy Technologies Inc , Program Leader , Small Business Innovation , National Institutes , Business Wire , Daunch Phd , Technology Officer ,

Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial

Press release content from Business Wire. The AP news staff was not involved in its creation.
Advanced Chemotherapy Technologies, Inc. Announces $2.5M Series A Investment by Spectrum Financial
February 11, 2021 GMT
Advanced Chemotherapy Technologies ACT-IOP-003 iontophoresis chemotherapy delivery system (Photo: Business Wire)
RALEIGH, N.C. (BUSINESS WIRE) Feb 10, 2021
Advanced Chemotherapy Technologies, Inc., a clinical-stage drug delivery company, announced today that it has closed a Series A investment of $2.5 million with Spectrum Financial. This investment is in addition to the previously announced Series A investment of $5.5 million lead by Khosla Venture. The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer. ....

North Carolina , United States , University Of North Carolina , Chapel Hill , Josephm Desimone , Jen Yeh , Bryan Martin , Carolina Biotechnology Center , Us National Institutes Of Health , Pioneer Award Program , Chemotherapy Technology , University Cancer Research Fund , Chemotherapy Technologies Inc , Lineberger Comprehensive Cancer Center , University Of North Carolina At Chapel Hill , Business Wire , Chief Investment Officer , Tony Voiers , Comprehensive Cancer , North Carolina Biotechnology Center , Pioneer Award , For More , Products And Services , Pancreatic Cancer , Product Testing , Diagnosis And Treatment ,